Frontlight ResearchEarly access
Ovarian cancer trials in Serbia
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1CompletedA Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Where
- Belgrade
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See details and how to joinNCT04516447 · EU 2025-524868-38-00